Literature DB >> 17389531

Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.

J-P Durand, B Gourmel, O Mir, F Goldwasser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389531     DOI: 10.1093/annonc/mdm104

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.

Authors:  Seiko Bun; Kan Yonemori; Toru Akagi; Emi Noguchi; Tatsunori Shimoi; Akihiko Shimomura; Mayu Yunokawa; Chikako Shimizu; Yasuhiro Fujiwara; Yoshinori Makino; Yoshikazu Hayashi; Kenji Tamura
Journal:  Invest New Drugs       Date:  2017-07-21       Impact factor: 3.850

Review 2.  Aprepitant and fosaprepitant drug interactions: a systematic review.

Authors:  Priya Patel; J Steven Leeder; Micheline Piquette-Miller; L Lee Dupuis
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

3.  Two cases of fatal encephalopathy related to Ifosfamide: an adverse role of aprepitant?

Authors:  Alice Séjourné; Sabine Noal; Mathieu Boone; Céline Bihan; Marion Sassier; Michel Andrejak; Bruno Chauffert
Journal:  Case Rep Oncol       Date:  2014-09-25

4.  Ifosfamide-induced Encephalopathy Precipitated by Aprepitant: A Rarely Manifested Side Effect of Drug Interaction.

Authors:  Pritam Sureshchandra Kataria; Pradip Piraji Kendre; Apurva A Patel
Journal:  J Pharmacol Pharmacother       Date:  2017 Jan-Mar

5.  Case reports and the fight against cancer.

Authors:  Elie G Dib; Michael R Kidd; Deborah C Saltman
Journal:  J Med Case Rep       Date:  2008-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.